Evidence map›Paper›PMID 41993871›Full record

ArticleFrontiers in toxicology2026

Clinical characteristics in

Lei Wu, Congli Yang, Yangshan Fu, Ruiling Zuo, Xingcheng Li, Junyue Hu, Shibiao Fu, Yaowu Chen, Wenfang Zhang, Fenshuang Zheng

Abstract read
In one paragraph

Article in Frontiers in toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lei Wu *Dali University, Dali, China.
Congli Yang *Baoshan People's Hospital, Baoshan, China.
Yangshan FuThe Affiliated Hospital of Yunnan University, Kunming, China.
Ruiling ZuoThe Affiliated Hospital of Yunnan University, Kunming, China.
Xingcheng LiThe Affiliated Hospital of Yunnan University, Kunming, China.
Junyue HuThe People's Hospital of Wenshan Prefecture, Wenshan, China.
Shibiao FuMile City Traditional Chinese Medicine Hospital, Mile, China.
Yaowu ChenLijiang People's Hospital, Lijiang, China.
Wenfang ZhangThe Affiliated Hospital of Yunnan University, Kunming, China.
Fenshuang ZhengThe Affiliated Hospital of Yunnan University, Kunming, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mushroom poisoning, a form of foodborne intoxication, poses serious life-threatening risks in severe cases. Methods: We conducted a retrospective analysis of 103 patients with confirmed highly suspected Russula subnigricans poisoning admitted to the Affiliated Hospital of Yunnan University between 2020 and 2024. Data encompassed epidemiological characteristics, clinical manifestation, laboratory findings, and treatment outcomes. Results: Patients were predominantly middle-aged (61.2%) and from Yunnan Province (93.2%), with most poisonings (93.2%) resulting from Self-picking. Symptom onset was rapid (median latency, 2.4 h), primarily featuring gastrointestinal, cardiovascular, and rhabdomyolysis-related manifestations. Laboratory findings revealed high rates of hepatotoxicity (97.1%) and myocardial injury (85.4%). A combination of conventional therapy and blood purification was employed in 60.2% of cases, yielding favorable outcomes. After treatment at Yunnan University Affiliated Hospital, the final clinical outcomes were as follows: 91 patients (88.3%) recovered and were discharged. Conclusion:

Indexed as

blood purificationmushroom poisoningrhabdomyolysisRussula subnigricanstreatment

Identifiers

PMID41993871
PMCPMC13082752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.